16 Recruiting Graft Vs Host Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Graft Vs Host Disease
Related Conditions
Top Recruiting Graft Vs Host Disease Studies
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔Horizons Chronic Graft-Versus-Host-Disease Study
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Pediatric cGVHD Symptom Scale
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔Chronic GVHD Response Measures Validation
📍 Fred Hutchinson Cancer Research Center — Seattle, Washington
View Study & Checklist ➔A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
📍 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
📍 Zuckerberg Cancer Center — Lake Success, New York
View Study & Checklist ➔Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
📍 City Of Hope National Medical Center — Duarte, California
View Study & Checklist ➔